Clinical Trial Update: Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating intermittent fasting in individuals at high risk for pancreatic cancer undergoing screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Evaluating, Intermittent Fasting | NA | Status: NOT_YET_RECRUITING